Cargando…
Investigation of barriers to clinical practice guideline-recommended pharmacotherapy in the treatment of COPD
BACKGROUND: The adoption of clinical practice guideline recommendations for COPD is suboptimal. Determining the barriers to the implementation of these practice guidelines may help improve patient care. OBJECTIVE: To determine whether barriers to the use of pharmacotherapy according to practice guid...
Autores principales: | Price, Lea, Billups, Sarah J., Rice, Melissa A., Hartsfield, Cynthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155154/ https://www.ncbi.nlm.nih.gov/pubmed/25214921 |
Ejemplares similares
-
Defining ‘elderly’ in clinical practice guidelines for pharmacotherapy
por: Singh, Shamsher, et al.
Publicado: (2014) -
Pharmacotherapies for COPD
por: Ejiofor, Stan, et al.
Publicado: (2013) -
Impact of a Clinical Pharmacy Anemia Management Service on Adherence to Monitoring Guidelines, Clinical Outcomes, and Medication Utilization
por: Debenito, Jenny M., et al.
Publicado: (2014) -
Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD
por: Grewe, Fabian A, et al.
Publicado: (2020) -
Positioning new pharmacotherapies for COPD
por: Barjaktarevic, Igor Z, et al.
Publicado: (2015)